SAN DIEGO — In this exclusive video from DDW 2016, Sudarshan Paramsothy, MD, from St. Vincent’s Clinical School, University of South Wales, Australia, discusses randomized controlled trial data showing intense multi-donor fecal microbiota transplantation was effective for inducing clinical and endoscopic remission in patients with resistant active ulcerative colitis.
“Our trial involved intensive fecal microbiota transplantation performed in a randomized double blind controlled study. Patients with active ulcerative colitis were randomized in a one-to-one manner to either FMT or placebo therapy,” he said. “We found that patients who received fecal microbiota transplantation had a significant improvement in their outcomes compared to the patients who were randomized to the placebo arm.”
Paramsothy S, et al. Abstract #600. Presented at: Digestive Disease Week; May 21-24, 2016; San Diego.
Disclosures: Paramsothy reports no relevant financial disclosures.